203 related articles for article (PubMed ID: 12566310)
1. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer.
Wang Z; Lo HS; Yang H; Gere S; Hu Y; Buetow KH; Lee MP
Cancer Res; 2003 Feb; 63(3):655-7. PubMed ID: 12566310
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics detection of alternative splicing.
Kim N; Lee C
Methods Mol Biol; 2008; 452():179-97. PubMed ID: 18566765
[TBL] [Abstract][Full Text] [Related]
3. Expressed sequence tags: clean before using. Correspondence re: Z. Wang et al., computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Res., 63: 655-657, 2003.
Sorek R; Basechess O; Safer HM
Cancer Res; 2003 Oct; 63(20):6996; author reply 6996-7. PubMed ID: 14583502
[No Abstract] [Full Text] [Related]
4. Identification of human exons overexpressed in tumors through the use of genome and expressed sequence data.
Kirschbaum-Slager N; Parmigiani RB; Camargo AA; de Souza SJ
Physiol Genomics; 2005 May; 21(3):423-32. PubMed ID: 15784694
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array.
Gardina PJ; Clark TA; Shimada B; Staples MK; Yang Q; Veitch J; Schweitzer A; Awad T; Sugnet C; Dee S; Davies C; Williams A; Turpaz Y
BMC Genomics; 2006 Dec; 7():325. PubMed ID: 17192196
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidates for tumor-specific alternative splicing in the thyroid.
Guimarães GS; Latini FR; Camacho CP; Maciel RM; Dias-Neto E; Cerutti JM
Genes Chromosomes Cancer; 2006 Jun; 45(6):540-53. PubMed ID: 16493598
[TBL] [Abstract][Full Text] [Related]
7. Multiple alternative splicing markers for ovarian cancer.
Klinck R; Bramard A; Inkel L; Dufresne-Martin G; Gervais-Bird J; Madden R; Paquet ER; Koh C; Venables JP; Prinos P; Jilaveanu-Pelmus M; Wellinger R; Rancourt C; Chabot B; Abou Elela S
Cancer Res; 2008 Feb; 68(3):657-63. PubMed ID: 18245464
[TBL] [Abstract][Full Text] [Related]
8. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
Wang XQ; Luk JM; Leung PP; Wong BW; Stanbridge EJ; Fan ST
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):483-9. PubMed ID: 15701831
[TBL] [Abstract][Full Text] [Related]
9. An efficient and high-throughput approach for experimental validation of novel human gene predictions.
Brzoska PM; Brown C; Cassel M; Ceccardi T; Di Francisco V; Dubman A; Evans J; Fang R; Harris M; Hoover J; Hu F; Larry C; Li P; Malicdem M; Maltchenko S; Shannon M; Perkins S; Poulter K; Webster-Laig M; Xiao C; Young S; Spier G; Guegler K; Gilbert D; Samaha RR
Genomics; 2006 Apr; 87(4):437-45. PubMed ID: 16406193
[TBL] [Abstract][Full Text] [Related]
10. Sequence, "subtle" alternative splicing and expression of the CYYR1 (cysteine/tyrosine-rich 1) mRNA in human neuroendocrine tumors.
Vitale L; Frabetti F; Huntsman SA; Canaider S; Casadei R; Lenzi L; Facchin F; Carinci P; Zannotti M; Coppola D; Strippoli P
BMC Cancer; 2007 Apr; 7():66. PubMed ID: 17442112
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide detection of testis- and testicular cancer-specific alternative splicing.
He C; Zuo Z; Chen H; Zhang L; Zhou F; Cheng H; Zhou R
Carcinogenesis; 2007 Dec; 28(12):2484-90. PubMed ID: 17724370
[TBL] [Abstract][Full Text] [Related]
12. In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions.
Aouacheria A; Navratil V; López-Pérez R; Gutiérrez NC; Churkin A; Barash D; Mouchiroud D; Gautier C
BMC Genomics; 2007 Jan; 8():2. PubMed ID: 17201911
[TBL] [Abstract][Full Text] [Related]
13. Computational methods for alternative splicing prediction.
Bonizzoni P; Rizzi R; Pesole G
Brief Funct Genomic Proteomic; 2006 Mar; 5(1):46-51. PubMed ID: 16769678
[TBL] [Abstract][Full Text] [Related]
14. PCR isolation and cloning of novel splice variant mRNAs from known drug target genes.
Jin P; Fu GK; Wilson AD; Yang J; Chien D; Hawkins PR; Au-Young J; Stuve LL
Genomics; 2004 Apr; 83(4):566-71. PubMed ID: 15028279
[TBL] [Abstract][Full Text] [Related]
15. Identification of alternative splicing markers for breast cancer.
Venables JP; Klinck R; Bramard A; Inkel L; Dufresne-Martin G; Koh C; Gervais-Bird J; Lapointe E; Froehlich U; Durand M; Gendron D; Brosseau JP; Thibault P; Lucier JF; Tremblay K; Prinos P; Wellinger RJ; Chabot B; Rancourt C; Elela SA
Cancer Res; 2008 Nov; 68(22):9525-31. PubMed ID: 19010929
[TBL] [Abstract][Full Text] [Related]
16. Splice variants as cancer biomarkers.
Brinkman BM
Clin Biochem; 2004 Jul; 37(7):584-94. PubMed ID: 15234240
[TBL] [Abstract][Full Text] [Related]
17. ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome.
Croft L; Schandorff S; Clark F; Burrage K; Arctander P; Mattick JS
Nat Genet; 2000 Apr; 24(4):340-1. PubMed ID: 10742092
[No Abstract] [Full Text] [Related]
18. Genome-wide assembly and analysis of alternative transcripts in mouse.
Sharov AA; Dudekula DB; Ko MS
Genome Res; 2005 May; 15(5):748-54. PubMed ID: 15867436
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide detection and analysis of alternative splicing for nucleotide binding site-leucine-rich repeats sequences in rice.
Gu L; Guo R
J Genet Genomics; 2007 Mar; 34(3):247-57. PubMed ID: 17498622
[TBL] [Abstract][Full Text] [Related]
20. Reconstruction of full-length isoforms from splice graphs.
Xing Y; Lee C
Methods Mol Biol; 2008; 452():199-205. PubMed ID: 18566766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
